Ekso Bionics (EKSO) Misses Q2 EPS by 116c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EKSO Hot Sheet
Join SI Premium – FREE
Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($1.24), $1.16 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $2.06 million versus the consensus estimate of $5.51 million.
For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi initiates ATI Inc. coverage with Buy rating, $229 target
- CompX International (CIX) Reports Q3 EPS of $0.44
- Timken (TKR) PT Lowered to $126 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
